Zevra Therapeutics, Inc. Investing Cash Flow
Zevra Therapeutics, Inc. (ZVRA) reported Investing Cash Flow of $111.07 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-05
- Zevra Therapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $31.45M, a 163.54% increase year-over-year.
- Zevra Therapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $79.62M, a 655.25% increase year-over-year.
- Zevra Therapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $227.00K.
- Zevra Therapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$4.58M.
- Zevra Therapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2025 was $18.13M.
- Zevra Therapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2024 was -$22.16M.
- Zevra Therapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2023 was -$17.39M.
- Zevra Therapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2022 was -$36.72M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $31.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $111.07M 10-Q · filed 2026-08-05 | $111.30M derived: sum of 3 quarters · filed 2026-08-05 | $106.72M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $79.62M 10-Q · filed 2026-05-06 | $79.84M derived: sum of 2 quarters · filed 2026-05-06 | $75.27M derived: sum of 3 quarters · filed 2026-05-06 | $87.20M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $227.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$4.35M derived: sum of 2 quarters · filed 2026-03-09 | $7.58M derived: sum of 3 quarters · filed 2026-08-05 | $18.13M 10-K · filed 2026-03-09 |
| 2025-09-30 | -$4.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $7.36M derived: sum of 2 quarters · filed 2026-08-05 | $17.90M 10-Q · filed 2025-11-05 | $12.43M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $11.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $22.48M 10-Q · filed 2026-08-05 | $17.00M derived: sum of 3 quarters · filed 2026-08-05 | -$14.35M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $10.54M 10-Q · filed 2026-05-06 | $5.07M derived: sum of 2 quarters · filed 2026-05-06 | -$26.28M derived: sum of 3 quarters · filed 2026-05-06 | -$26.41M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$5.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$36.83M derived: sum of 2 quarters · filed 2026-03-09 | -$36.95M derived: sum of 3 quarters · filed 2026-03-09 | -$22.16M 10-K · filed 2026-03-09 |
| 2024-09-30 | -$31.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$31.48M derived: sum of 2 quarters · filed 2025-11-05 | -$16.69M 10-Q · filed 2025-11-05 | -$6.11M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | -$129.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $14.66M 10-Q · filed 2025-08-12 | $25.25M derived: sum of 3 quarters · filed 2025-08-12 | -$19.21M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $14.79M 10-Q · filed 2025-05-13 | $25.38M derived: sum of 2 quarters · filed 2025-05-13 | -$19.08M derived: sum of 3 quarters · filed 2025-05-13 | $14.96M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $10.59M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | -$33.87M derived: sum of 2 quarters · filed 2025-03-12 | $165.00K derived: sum of 3 quarters · filed 2025-03-12 | -$17.39M 10-K · filed 2025-03-12 |
| 2023-09-30 | -$44.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$10.42M derived: sum of 2 quarters · filed 2024-11-13 | -$27.98M 10-Q · filed 2024-11-13 | -$28.04M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $34.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $16.48M 10-Q · filed 2024-08-14 | $16.42M derived: sum of 3 quarters · filed 2024-08-14 | $16.69M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | -$17.55M 10-Q · filed 2024-05-09 | -$17.62M derived: sum of 2 quarters · filed 2024-05-09 | -$17.35M derived: sum of 3 quarters · filed 2024-05-09 | -$50.43M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | -$63.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $209.00K derived: sum of 2 quarters · filed 2024-04-01 | -$32.87M derived: sum of 3 quarters · filed 2024-04-01 | -$36.72M 10-K · filed 2024-04-01 |
| 2022-09-30 | $272.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$32.81M derived: sum of 2 quarters · filed 2023-11-07 | -$36.66M 10-Q · filed 2023-11-07 | -$52.09M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$33.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$36.93M 10-Q · filed 2023-08-14 | -$52.37M derived: sum of 3 quarters · filed 2023-08-14 | -$52.37M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$3.85M 10-Q · filed 2023-05-15 | -$19.29M derived: sum of 2 quarters · filed 2023-05-15 | -$19.29M derived: sum of 3 quarters · filed 2023-05-15 | -$19.37M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$15.44M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | -$15.44M derived: sum of 2 quarters · filed 2023-03-07 | -$15.52M derived: sum of 3 quarters · filed 2023-03-07 | -$15.52M 10-K · filed 2023-03-07 |
| 2021-09-30 | -$4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$85.00K derived: sum of 2 quarters · filed 2022-11-10 | -$85.00K 10-Q · filed 2022-11-10 | -$111.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$81.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$81.00K 10-Q · filed 2022-08-12 | -$107.00K derived: sum of 3 quarters · filed 2022-08-12 | -$107.00K derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-12 | -$26.00K derived: sum of 2 quarters · filed 2022-05-12 | -$26.00K derived: sum of 3 quarters · filed 2022-05-12 | -$22.00K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | -$26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$26.00K derived: sum of 2 quarters · filed 2022-03-31 | -$22.00K derived: sum of 3 quarters · filed 2022-03-31 | -$33.00K 10-K · filed 2022-03-31 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $4.00K derived: sum of 2 quarters · filed 2021-11-10 | -$7.00K 10-Q · filed 2021-11-10 | -$12.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | -$7.00K 10-Q · filed 2021-08-13 | -$12.00K derived: sum of 3 quarters · filed 2021-08-13 | -$16.00K derived: sum of 4 quarters · filed 2021-08-13 |
| 2020-03-31 | -$11.00K 10-Q · filed 2021-05-14 | -$16.00K derived: sum of 2 quarters · filed 2021-05-14 | -$20.00K derived: sum of 3 quarters · filed 2021-05-14 | -$20.00K derived: sum of 4 quarters · filed 2021-05-14 |
| 2019-12-31 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | -$9.00K derived: sum of 2 quarters · filed 2021-03-12 | -$9.00K derived: sum of 3 quarters · filed 2021-03-12 | $3.23M 10-K · filed 2021-03-12 |
| 2019-09-30 | -$4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | -$4.00K derived: sum of 2 quarters · filed 2020-10-30 | $3.24M 10-Q · filed 2020-10-30 | $11.20M derived: sum of 4 quarters · filed 2020-10-30 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $3.24M 10-Q · filed 2020-08-12 | $11.21M derived: sum of 3 quarters · filed 2020-08-12 | $11.66M derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | $3.24M 10-Q · filed 2020-05-13 | $11.21M derived: sum of 2 quarters · filed 2020-05-13 | $11.66M derived: sum of 3 quarters · filed 2020-05-13 | $27.35M derived: sum of 4 quarters · filed 2020-05-13 |
| 2018-12-31 | $7.96M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $8.42M derived: sum of 2 quarters · filed 2020-02-28 | $24.10M derived: sum of 3 quarters · filed 2020-02-28 | $33.33M 10-K · filed 2020-02-28 |
| 2018-09-30 | $457.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $16.14M derived: sum of 2 quarters · filed 2019-11-14 | $25.37M 10-Q · filed 2019-11-14 | $35.38M derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | $15.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $24.91M 10-Q · filed 2019-08-13 | $34.93M derived: sum of 3 quarters · filed 2019-08-13 | $40.58M derived: sum of 4 quarters · filed 2019-08-13 |
| 2018-03-31 | $9.23M 10-Q · filed 2019-05-14 | $19.25M derived: sum of 2 quarters · filed 2019-05-14 | $24.90M derived: sum of 3 quarters · filed 2019-05-14 | $30.94M derived: sum of 4 quarters · filed 2019-05-14 |
| 2017-12-31 | $10.02M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $15.67M derived: sum of 2 quarters · filed 2019-03-01 | $21.71M derived: sum of 3 quarters · filed 2019-03-01 | $27.41M 10-K · filed 2019-03-01 |
| 2017-09-30 | $5.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $11.69M derived: sum of 2 quarters · filed 2018-11-09 | $17.40M 10-Q · filed 2018-11-09 | $23.14M derived: sum of 4 quarters · filed 2018-11-09 |
| 2017-06-30 | $6.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | $11.74M 10-Q · filed 2018-08-10 | $17.48M derived: sum of 3 quarters · filed 2018-08-10 | |
| 2017-03-31 | $5.70M 10-Q · filed 2018-05-11 | $11.44M derived: sum of 2 quarters · filed 2018-05-11 | ||
| 2016-12-31 | $5.74M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | -$45.85M 10-K · filed 2018-03-30 | ||
| 2016-09-30 | -$51.59M 10-Q · filed 2017-11-09 | |||
| 2015-12-31 | -$19.14M 10-K · filed 2018-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |